The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles

[1]  S. Skouby,et al.  Effects of letrozole cotreatment on endocrinology and follicle development in women undergoing ovarian stimulation in an antagonist protocol. , 2022, Human reproduction.

[2]  P. Humaidan,et al.  Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer , 2019, Front. Endocrinol..

[3]  A. Abdelaziz,et al.  Effect of follicular diameter at the time of ovulation triggering on pregnancy outcomes during intrauterine insemination , 2017, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[4]  M. Hill,et al.  GnRH Agonist versus hCG Trigger in Ovulation Induction with Intrauterine Insemination: A Randomized Controlled Trial , 2017, International journal of endocrinology.

[5]  S. Esteves,et al.  GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles—A Systematic PRISMA Review and Meta-analysis , 2017, Front. Endocrinol..

[6]  R. Taheripanah,et al.  Comparing the effect of gonadotropin-releasing hormone agonist and human chorionic gonadotropin on final oocytes for ovulation triggering among infertile women undergoing intrauterine insemination: An RCT , 2017, International journal of reproductive biomedicine.

[7]  Jiayin Liu,et al.  The impact of ovarian stimulation on the outcome of intrauterine insemination treatment: an analysis of 8893 cycles , 2016, BJOG : an international journal of obstetrics and gynaecology.

[8]  S. Siam,et al.  Pregnancy rate after ovulation triggering with gonadotrophin releasing hormone agonist versus human chorionic gonadotrophin in women undergoing controlled ovarian stimulation/intrauterine insemination , 2014 .

[9]  L. Engmann,et al.  Maternal and neonatal outcomes after gonadotropin-releasing hormone agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization. , 2014, Fertility and sterility.

[10]  E. Papanikolaou,et al.  GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. , 2013, Human reproduction.

[11]  M. Ashrafi,et al.  The Role of Infertility Etiology in Success Rate of Intrauterine Insemination Cycles: An Evaluation of Predictive Factors for Pregnancy Rate , 2013, International journal of fertility & sterility.

[12]  A. Pellicer,et al.  FSH receptor in vitro modulation by testosterone and hCG in human luteinized granulosa cells. , 2012, European journal of obstetrics, gynecology, and reproductive biology.

[13]  S. Daneshmand,et al.  Comparison of "triggers" using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin. , 2011, Fertility and sterility.

[14]  M. Elsedeek,et al.  Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women , 2011 .

[15]  O. Cinar,et al.  Factors affecting pregnancy outcome of intrauterine insemination cycles in couples with favourable female characteristics , 2011, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[16]  P. Devroey,et al.  Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation. , 2010, Human reproduction.

[17]  P. Humaidan,et al.  1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. , 2010, Fertility and sterility.

[18]  M. Farré,et al.  Use of letrozole in assisted reproduction: a systematic review and meta-analysis , 2008, Human reproduction update.

[19]  M. Huleihel,et al.  Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. , 2006, Human reproduction.

[20]  Lisa M Mehlmann,et al.  Focus on Meiosis Stops and starts in mammalian oocytes: recent advances in understanding the regulation of meiotic arrest and oocyte maturation , 2005 .

[21]  P. Humaidan,et al.  GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. , 2005, Human reproduction.

[22]  R. Casper,et al.  Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination , 2004, Reproductive biology and endocrinology : RB&E.

[23]  A. Kruif,et al.  Intra-uterine insemination in farm animals and humans. , 2004, Reproduction in domestic animals = Zuchthygiene.

[24]  M. Eijkemans,et al.  Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with rec , 2003, The Journal of clinical endocrinology and metabolism.

[25]  S. Oehninger,et al.  Intrauterine insemination: a systematic review on determinants of success , 2002 .

[26]  J. Itskovitz‐Eldor,et al.  Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. , 2002, The Journal of clinical endocrinology and metabolism.

[27]  A. Byskov,et al.  FSH-induced resumption of meiosis in mouse oocytes: effect of different isoforms. , 1999, Molecular human reproduction.

[28]  A. Romeu,et al.  Endogenous LH Surge Versus hCG as Ovulation Trigger After Low-Dose Highly Purified FSH in IUI: A Comparison of 761 Cycles , 1997, Journal of Assisted Reproduction and Genetics.

[29]  J. Sanfilippo,et al.  Induction of luteal phase defect with clomiphene citrate. , 1984, American journal of obstetrics and gynecology.

[30]  A. C. Wentz.  Endometrial biopsy in the evaluation of infertility. , 1980, Fertility and sterility.

[31]  A. C. Wentz,et al.  The use of clomiphene citrate. , 1977, Fertility and sterility.

[32]  H. Copin,et al.  Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1038 cycles and a review of the literature. , 2010, Fertility and sterility.

[33]  P. Humaidan,et al.  Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. , 2006, Reproductive biomedicine online.

[34]  E. Kolibianakis,et al.  Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. , 2004, Reproductive biomedicine online.

[35]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..